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There has been unprecedented progress in vaccine development 
against SARS-CoV-2, the virus that causes COVID-19. However, 
given the huge demand for a limited supply of efficacious vaccines, 
there has been global, regional and local outcry regarding the lack of 
access to vaccines and the equity of distribution. Over 319 million 
vaccine doses have been administered (at the time of writing), with 
the majority in high-income countries.[1,2] In contrast, by mid-January 
2021, Guinea was the sole low-income country to have administered 
vaccines, but to only 25 individuals.[3] Early in February 2021, South 
Africa (SA) received one million doses of the AstraZeneca vaccine; 
however, shortly thereafter, data reflected disappointing results on 
the efficacy of this vaccine on the predominant strain in the country 
(the 501Y.V2 variant), prompting the country to reverse the decision 
to utilise these in the national roll-out. With ample agility, on 
17 February 2021 SA launched an early-access programme through 
a phase 3B open-label study using the Johnson & Johnson vaccine 
candidate, rapidly deploying the first tranche of 80 000 vaccines 
within hours of the vaccines touching down on SA soil.
Despite global surveillance efforts and the promise of numerous 
vaccine candidates, ongoing public health challenges to fully understand 
the impact of the COVID-19 pandemic remain a major concern. 
COVID-19 testing data have become a key metric that informs public 
health decision-making. However, epidemiological indicators can 
be flawed, as they may be influenced by insufficient testing capacity, 
limited access to healthcare facilities and testing bias, as individuals 
with severe symptoms are more likely to be tested than asymptomatic 
individuals.[4,5] While African countries have reported low COVID-19 
case numbers relative to other regions, this may not be indicative of 
low prevalence or spread containment, but rather low surveillance.[6]
Wastewater surveillance as an early 
warning system
Wastewater-based epidemiology has played an important role in the 
development of early warning systems for various enteric viruses, 
including poliovirus, norovirus and hepatitis. The detection of 
SARS-CoV-2 RNA in faeces and urine stimulated rapid research 
into wastewater surveillance for SARS-CoV-2. A wastewater sample 
collected from a wastewater treatment plant can represent the 
point prevalence of disease within the catchment community. 
Wastewater surveillance for SARS-CoV-2 is now carried out in over 
50 countries[1,7] to screen for disease presence in populations, provide 
an early warning for detection of COVID-19 cases in the community, 
monitor trends and track hot spots.[8]
In SA, a key milestone was both confirming the presence of SARS-
CoV-2 viral RNA (qualitative analysis) and determining the RNA 
copy number of SARS-CoV-2 viral RNA by reverse transcription 
polymerase chain reaction (quantitative analysis).[9] The South 
African Medical Research Council’s SARS-CoV-2 wastewater research 
and surveillance programme has set up wastewater monitoring 
in four provinces, namely Eastern Cape, Western Cape, Limpopo 
and Gauteng. The monitoring currently covers over 45  wastewater 
treatment plants with a total catchment population of ~4 million 
inhabitants. Results of the SARS-CoV-2 RNA signal are uploaded 
weekly on a dashboard (https://www.samrc.ac.za/wbe/) freely 
accessible to the public. Additional sampling sites are being added as 
the programme aims to expand surveillance to enable monitoring of 
hotspots, variants and other emerging pathogens.
Can wastewater surveillance detect a 
COVID-19 vaccine-induced break in 
transmission?
An efficacious COVID-19 vaccine, to prevent infection, disease or 
transmission, is essential for controlling the pandemic.[10] Wastewater 
surveillance has the potential for use as a public health tool for 
guiding and monitoring national vaccine efforts.[11] Firstly, in order 
to measure vaccine efficacy in real-world settings, there is a reliance 
on ongoing transmission of SARS-CoV-2, which is contradictory to 
public health promotion efforts.[10] The level of ongoing community 
transmission can be monitored in wastewater, which in turn may 
provide insights into the impact of the vaccination programmes. 
Secondly, there are currently limited data on the efficacy of the 
current generation of vaccines to protect against COVID-19 variants. 
Wastewater monitoring may provide evidence on the SARS-CoV-2 
RNA viral load and viral shedding trends during the roll-out of 
vaccinations in communities. Thirdly, for vaccinated, unvaccinated 
or mixed populations, wastewater surveillance can provide an early 
warning system for prioritising hotspots where vaccination coverage 
is most urgently required. And lastly, targeted and untargeted 
sequencing of wastewater pathogens has the potential to track the 
spread of specific sequence variants and identify mutations for which 
vaccinations may be need be modified.[12]
In conclusion, wastewater surveillance is currently being expanded 
in SA with a view to early detection of the imminent third wave of 
COVID-19. Recognising the shortage of resources and capacity to 
counteract COVID-19 in the country, including limited numbers of 
vaccines available, the expanded wastewater surveillance and early 
warning system could also be applied as a potentially efficient and 
cost-effective mechanism to evaluate the efficacy of the vaccination 
roll-out and identify locations where COVID-19 transmission 
remains intractable. It also holds the promise of supporting the 
long-term goal of monitoring COVID-19 disease absence in 
communities.
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